Guideline Development for Medical Device Technology: Issues for Consideration
Journal of Diabetes Science and Technology, vol. 17, pp. 1698–1710
Abstract
Advances in the development of innovative medical devices and telehealth technologies create the potential to improve the quality and efficiency of diabetes care through collecting, aggregating, and interpreting relevant health data in ways that facilitate more informed decisions among all stakeholder groups. Although many medical societies publish guidelines for utilizing these technologies in clinical practice, we believe that the methodologies used for the selection and grading of the evidence should be revised. In this article, we discuss the strengths and limitations of the various types of research commonly used for evidence selection and grading and present recommendations for modifying the process to more effectively address the rapid pace of device and technology innovation and new product development.
Authors 18
-
University of Ljubljana · Ljubljana University Medical Centre
Affiliation as printed
University Medical Center Ljubljana, University of Ljubljana, Ljubljana, Slovenia
-
Affiliation as printed
University of Arizona College of Medicine–Tucson, AZ, USA
-
Affiliation as printed
IRCCS MultiMedica, Milan, Italy
-
Karolinska University Hospital · Karolinska Institutet
Affiliation as printed
Cardiology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
-
Affiliation as printed
Duke University Medical Center, Duke Clinical Research Institute, Durham, NC, USA
-
Affiliation as printed
Marienhospital Stuttgart, Stuttgart, Germany
-
Affiliation as printed
PCNA National Office, Madison, WI, USA
-
UNSW Sydney · The George Institute for Global Health · Saint Luke's Hospital · University of Missouri–Kansas City
Affiliation as printed
Saint Luke’s Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA
The George Institute for Global Health, University of New South Wales, Sydney, Australia
Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA
-
University of Belgrade · Univerzitetski Klinički Centar Srbije
Affiliation as printed
Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia
-
Universitätsklinikum Aachen · RWTH Aachen University
Affiliation as printed
Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany
-
Affiliation as printed
American Heart Association, Dallas, TX, USA
-
Affiliation as printed
Department of Medicine K2, Karolinska Institute, Stockholm, Sweden
-
Affiliation as printed
Endocrine and Metabolic Consultants, Rockville, MD, USA
-
Peking University People's Hospital
Affiliation as printed
Peking University People’s Hospital, Beijing, China
Peking University People's Hospital, Beijing, China
-
Taichung Veterans General Hospital
Affiliation as printed
Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung City
-
Affiliation as printed
Forschergruppe Diabetes e.V., Munich, Germany
-
Affiliation as printed
CGParkin Communications Inc., Henderson, NV, USA
-
Oliver Schnell corresponding
Affiliation as printed
Forschergruppe Diabetes e.V., Munich, Germany
Cited by 4 stored of 4
4 results
No patents citing this paper on Lens.org (checked 2026-10-06).